Scientists probe Weight-Loss Drug's hidden effects on gut health
NCT ID NCT07323134
Summary
This study aims to understand how the medication semaglutide changes the gut bacteria of people with obesity. Researchers will enroll 40 adults and analyze stool samples before and after 12 weeks of treatment. The goal is to learn the specific ways this drug might work through the gut microbiome.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.